Trivedi et al. and Guo et al. highlighted NF-κB’s multifaceted involvement in inflammation, apoptosis resistance, and tumor progression, and emphasized the therapeutic potential of NF-κB inhibition in cancer therapy [12,25]. This evidence concerns the gene NFKB1 and cancer.